AR104274A1 - Compuestos piridinio como inhibidores de pag - Google Patents
Compuestos piridinio como inhibidores de pagInfo
- Publication number
- AR104274A1 AR104274A1 ARP160100917A ARP160100917A AR104274A1 AR 104274 A1 AR104274 A1 AR 104274A1 AR P160100917 A ARP160100917 A AR P160100917A AR P160100917 A ARP160100917 A AR P160100917A AR 104274 A1 AR104274 A1 AR 104274A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- aryl
- cycloalkyl
- heteroaryl
- carboxylic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/126—Acids containing more than four carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Reivindicación 1: Un compuesto de la fórmula (1) e isómeros, estereoisómeros, atropisómeros, confórmeros, tautómeros, polimorfos, hidratos y solvatos de los mismos; en donde, Y⁻ es anión de Y; Y se selecciona de ácido nítrico, C₂₋₁₂ alquil ácido sulfónico, C₃₋₁₂ cicloalquil ácido sulfónico, ácidos biliares primarios, ácidos biliares secundarios, ácidos biliares conjugados, CH₃-(CH₂)ᶻ-COOH, C₄₋₁₄ alcano ácido carboxílico ramificado, C₄₋₁₄ alqueno ácido carboxílico, C₄₋₁₄ alquino ácido carboxílico y C₃₋₁₂ cicloalcano ácido carboxílico; z se selecciona de 1 a 14; n se selecciona de 0 a 5; R¹ se selecciona independientemente de hidrógeno, C₁₋₈ alquilo, C₁₋₈ perhaloalquilo, C₃₋₈ cicloalquilo, hetero-C₃₋₁₄ cicloalquilo, arilo, aril-C₁₋₈ alquilo, heteroarilo, heteroaril-C₁₋₈ alquilo, C₁₋₈ alcoxi, carboxamido, -NHCO-C₁₋₈ alquilo, -NR⁵R⁶, acilo, aciloxi, C₁₋₈ alcoxicarbonilo, sulfonamido, halo, ciano y nitro; R² se selecciona de R⁴, -C(O)R⁴, -C(O)NHR⁴, -SO₂R⁴, -C(O)NR⁵R⁶ o estructura de fórmula (2); R³ se selecciona independientemente de C₁₋₈ alquilo, C₁₋₈ perhaloalquilo, C₃₋₈ cicloalquilo, hetero-C₃₋₁₄ cicloalquilo, arilo, aril-C₁₋₈ alquilo, heteroarilo, heteroaril-C₁₋₈ alquilo, C₁₋₈ alcoxi, ariloxi, amino,-NR⁵R⁶, -NHR⁴, aciloxi y sulfonamida; R⁴ se selecciona de C₁₋₈ alquilo, C₁₋₈ perhaloalquilo, C₃₋₈ cicloalquilo, hetero-C₃₋₁₄ cicloalquilo, arilo, aril-C₁₋₈ alquilo y heteroarilo; R⁵ y R⁶ se seleccionan independientemente de hidrógeno, C₁₋₈ alquilo, C₃₋₈ cicloalquilo, arilo, aril-C₁₋₈ alquilo y heteroarilo o R⁵ y R⁶ juntos podrán formar un anillo monocíclico o bicíclico de 4 - 8 miembros saturado o no saturado, podrán fusionarse con benceno que opcionalmente podrá contener uno a dos heteroátomos, seleccionados de O, N y S.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1473MU2015 | 2015-04-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR104274A1 true AR104274A1 (es) | 2017-07-12 |
Family
ID=55808799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160100917A AR104274A1 (es) | 2015-04-08 | 2016-04-05 | Compuestos piridinio como inhibidores de pag |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US10233175B2 (es) |
| EP (1) | EP3280711A1 (es) |
| JP (1) | JP6782763B2 (es) |
| KR (1) | KR20170134661A (es) |
| CN (1) | CN107438604B (es) |
| AR (1) | AR104274A1 (es) |
| AU (1) | AU2016245418B2 (es) |
| BR (1) | BR112017021631A2 (es) |
| CA (1) | CA2997364A1 (es) |
| EA (1) | EA035406B1 (es) |
| IL (1) | IL254792B (es) |
| MX (1) | MX2017012943A (es) |
| MY (1) | MY182914A (es) |
| PH (1) | PH12017501830A1 (es) |
| SG (1) | SG11201708140RA (es) |
| TW (1) | TWI710559B (es) |
| UA (1) | UA120389C2 (es) |
| WO (1) | WO2016162785A1 (es) |
| ZA (1) | ZA201707090B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2997364A1 (en) * | 2015-04-08 | 2016-10-13 | Torrent Pharmaceuticals Limited | Novel pyridinium compounds |
| LT3762368T (lt) | 2018-03-08 | 2022-06-10 | Incyte Corporation | Aminopirazindiolio junginiai, kaip pi3k-γ inhibitoriai |
| WO2020010003A1 (en) | 2018-07-02 | 2020-01-09 | Incyte Corporation | AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS |
| US20200338058A1 (en) * | 2019-04-28 | 2020-10-29 | King Faisal University | Therapeutic agents for treating and preventing autoimmune diseases and cancer and a screening method |
| WO2022238921A1 (en) * | 2021-05-14 | 2022-11-17 | Torrent Pharmaceuticals Limited | In-situ synthesis of 3-substituted pyridinium compounds |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2215000C2 (ru) * | 1999-10-06 | 2003-10-27 | Торрент Фармасьютикалз Лтд. | Производные солей пиридиния, способ их получения, фармацевтические композиции на их основе и способы лечения |
| PL348049A1 (en) * | 1999-10-06 | 2002-05-06 | Torrent Pharmaceuticals Ltd | Pyridinium derivatives for the treatment of diabetic and aging−related vascular complications |
| US6608094B2 (en) * | 1999-10-06 | 2003-08-19 | Torrent Pharmaceuticals Ltd. | Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| DK1243581T3 (da) | 2001-03-21 | 2005-10-31 | Torrent Pharmaceuticals Ltd | Pyridiniumforbindelser til behandling af AGE-relaterede sygdomme |
| PT1373263E (pt) | 2001-04-05 | 2005-03-31 | Torrent Pharmaceuticals Ltd | Compostos heterociclicos para complicacoes relacionadas com a idade e complicacoes vasculares diabeticas |
| EP1996588A4 (en) | 2006-03-03 | 2011-10-05 | Torrent Pharmaceuticals Ltd | NEW DUAL ACTION RECEPTOR (DARA) ANTAGONISTS OF ATI AND ETA RECEPTORS |
| CA2997364A1 (en) * | 2015-04-08 | 2016-10-13 | Torrent Pharmaceuticals Limited | Novel pyridinium compounds |
-
2016
- 2016-04-05 CA CA2997364A patent/CA2997364A1/en not_active Abandoned
- 2016-04-05 BR BR112017021631-0A patent/BR112017021631A2/pt not_active Application Discontinuation
- 2016-04-05 JP JP2018503834A patent/JP6782763B2/ja active Active
- 2016-04-05 CN CN201680020723.5A patent/CN107438604B/zh active Active
- 2016-04-05 UA UAA201710766A patent/UA120389C2/uk unknown
- 2016-04-05 KR KR1020177032034A patent/KR20170134661A/ko not_active Application Discontinuation
- 2016-04-05 SG SG11201708140RA patent/SG11201708140RA/en unknown
- 2016-04-05 EP EP16718473.8A patent/EP3280711A1/en not_active Withdrawn
- 2016-04-05 AR ARP160100917A patent/AR104274A1/es unknown
- 2016-04-05 EA EA201792234A patent/EA035406B1/ru not_active IP Right Cessation
- 2016-04-05 AU AU2016245418A patent/AU2016245418B2/en not_active Ceased
- 2016-04-05 MX MX2017012943A patent/MX2017012943A/es unknown
- 2016-04-05 US US15/564,715 patent/US10233175B2/en active Active
- 2016-04-05 MY MYPI2017001476A patent/MY182914A/en unknown
- 2016-04-05 WO PCT/IB2016/051917 patent/WO2016162785A1/en active Application Filing
- 2016-04-06 TW TW105110717A patent/TWI710559B/zh active
-
2017
- 2017-09-28 IL IL254792A patent/IL254792B/en active IP Right Grant
- 2017-10-06 PH PH12017501830A patent/PH12017501830A1/en unknown
- 2017-10-19 ZA ZA2017/07090A patent/ZA201707090B/en unknown
-
2019
- 2019-02-04 US US16/267,224 patent/US10717727B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| IL254792A0 (en) | 2017-12-31 |
| KR20170134661A (ko) | 2017-12-06 |
| CA2997364A1 (en) | 2016-10-13 |
| TW201639834A (zh) | 2016-11-16 |
| CN107438604B (zh) | 2021-12-03 |
| US10717727B2 (en) | 2020-07-21 |
| EA035406B1 (ru) | 2020-06-09 |
| US20190169175A1 (en) | 2019-06-06 |
| AU2016245418B2 (en) | 2020-03-26 |
| UA120389C2 (uk) | 2019-11-25 |
| WO2016162785A1 (en) | 2016-10-13 |
| JP2018511658A (ja) | 2018-04-26 |
| EP3280711A1 (en) | 2018-02-14 |
| MX2017012943A (es) | 2018-01-30 |
| MY182914A (en) | 2021-02-05 |
| JP6782763B2 (ja) | 2020-11-11 |
| US20180118728A1 (en) | 2018-05-03 |
| EA201792234A1 (ru) | 2018-02-28 |
| AU2016245418A1 (en) | 2017-11-02 |
| TWI710559B (zh) | 2020-11-21 |
| SG11201708140RA (en) | 2017-11-29 |
| PH12017501830A1 (en) | 2018-04-23 |
| US10233175B2 (en) | 2019-03-19 |
| BR112017021631A2 (pt) | 2018-07-03 |
| CN107438604A (zh) | 2017-12-05 |
| ZA201707090B (en) | 2021-03-31 |
| IL254792B (en) | 2021-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR104274A1 (es) | Compuestos piridinio como inhibidores de pag | |
| AR096684A1 (es) | Compuestos para tratar atrofia muscular espinal | |
| AR114631A1 (es) | Métodos e intermedios para preparar compuestos de piridina | |
| AR112774A1 (es) | Análogos de 1,2-dihidro-3h-pirazolo[3,4-d]pirimidin-3-ona | |
| CO2018004124A2 (es) | Compuestos heterocíclicos | |
| AR111524A1 (es) | Compuestos bicíclicos como inhibidores de atx | |
| AR100809A1 (es) | Inhibidores de fosfatidilinositol 3-quinasa | |
| AR103138A1 (es) | Compuestos de heteroarilo como inhibidores de la irak y usos de los mismos | |
| AR095011A1 (es) | Compuestos de antranilamida, sus mezclas y usos como plaguicidas | |
| AR113688A1 (es) | Proceso para la preparación de compuestos de piridiminio ópticamente activo | |
| AR089671A1 (es) | 1,4-dihidropirimidinas 4,4-disustituidas y su uso como medicamentos para el tratamiento de la hepatitis b | |
| AR091661A1 (es) | Inhibidores del virus de la hepatitis c | |
| AR099379A1 (es) | Compuestos tricíclicos como agentes antineoplásicos | |
| AR111407A1 (es) | Compuestos inhibidores de ask1 y usos de los mismos | |
| AR106100A1 (es) | Compuestos bicíclicos como inhibidores duales atx / ca | |
| AR106515A1 (es) | Sililfenoxiheterociclos trisustituidos y análogos | |
| AR100049A1 (es) | Derivados de dihidrotiazina y dihidrooxazina con actividad inhibidora de bace1 | |
| AR100439A1 (es) | Derivados de carboxamida | |
| AR102981A1 (es) | Inhibidores de la necrosis celular y métodos de preparación de los mismos | |
| AR090557A1 (es) | DERIVADOS IMIDAZOLICOS AGONISTAS ADRENERGICOS a2 | |
| AR113958A1 (es) | Macrociclos a como inhibidores de pde1 | |
| AR106047A1 (es) | Derivado de biarilo y medicamento que contiene el mismo para el tratamiento de infecciones fúngicas | |
| AR098965A1 (es) | Derivados de sulfonamidas tricíclicas | |
| AR088610A1 (es) | Compuestos plaguicidas | |
| AR097948A1 (es) | Inhibidores de la proteasa de cisteína catepsina |